Evidence mapPaperPMID 39778675Full record

ArticleJournal of cardiac failure2025

Predicted Mortality and Cardiology Follow-up Following Heart Failure Hospitalizations Among Veterans Health Administration Patients.

Rebecca L Tisdale, Fang Cao, Megan Skye, Orly Vardeny, Karim Sallam, Neil Kalwani, Stephanie Hsaio, Anubodh S Varshney, Paul A Heidenreich, Alexander T Sandhu

Abstract read
In one paragraph

Article in Journal of cardiac failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rebecca L TisdaleVeterans Affairs Palo Alto Health Care System, Palo Alto, California; Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, California. Electronic address: rtisdale@stanford.edu.
Fang CaoDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
Megan SkyeDivision of Cardiovascular Medicine and the Cardiovascular Institute, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Orly VardenyMinneapolis VA Center for Care Delivery and Outcomes Research, Minneapolis, Minnesota; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Karim SallamVeterans Affairs Palo Alto Health Care System, Palo Alto, California; Division of Cardiovascular Medicine and the Cardiovascular Institute, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Neil KalwaniVeterans Affairs Palo Alto Health Care System, Palo Alto, California; Division of Cardiovascular Medicine and the Cardiovascular Institute, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Stephanie HsaioVeterans Affairs Palo Alto Health Care System, Palo Alto, California; Division of Cardiovascular Medicine and the Cardiovascular Institute, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Anubodh S VarshneyDivision of Cardiovascular Medicine and the Cardiovascular Institute, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Paul A HeidenreichVeterans Affairs Palo Alto Health Care System, Palo Alto, California; Division of Cardiovascular Medicine and the Cardiovascular Institute, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Alexander T SandhuVeterans Affairs Palo Alto Health Care System, Palo Alto, California; Division of Cardiovascular Medicine and the Cardiovascular Institute, Department of Medicine, Stanford University School of Medicine, Stanford, California.

Funding

NHLBI NIH HHS K23 HL151672
6 · The paper itself

Abstract

backgroundGuidelines recommend timely follow-up with a cardiology specialist for patients hospitalized with heart failure (HF), but it is unknown whether the timeliness of specialty cardiovascular care after discharge correlates with clinical risk. We south to assess the association between estimated mortality risk and post-HF hospitalization cardiology follow-up. METHODS AND

resultsIn a cohort of veterans hospitalized with HF in acute care Veterans Health Administration (VA) hospitals between January 1, 2018, and September 15, 2022, we estimated the association of mortality risk at discharge with postdischarge cardiology encounters via logistic regression. We also evaluated the association between cardiology visits and sociodemographic and clinical characteristics, and described variability in postdischarge follow-up rates across VA facilities. We identified a cohort of 84,348 veterans hospitalized with HF with 120,619 hospital admissions. Of a subcohort of 57,554 veterans with 79,866 hospitalizations surviving at least 1 year after discharge, 32.1% of hospitalizations were followed by a cardiology visit within 2 weeks, and 49.3% within 1 month. Marginal probabilities of 2-week and 1-month follow-up were higher for hospitalizations in the highest-risk quintile than those in the lowest-risk quintile (34% vs. 30% and 51% vs. 47%, respectively; P < 0.001 for both intervals). In a time-to-event model in the full cohort, there was a slightly negative association between risk and likelihood of 1-month follow-up (coefficient for MAGGIC score = -0.004, 95% confidence interval [CI] -0.005 to -0.003). Black veterans were less likely to have either 2-week or 1-month follow-up (adjusted odds ratios, 0.93 [95% CI 0.90-0.97] for 2 weeks and 0.93 [95% CI 0.89-0.96] for 1 month). Female veterans were also less likely to have follow-up within 1 month of hospital discharge (adjusted odds ratio 0.90 [95% CI 0.90-0.98]). Conversely, patients with a primary vs secondary hospital diagnosis of HF and those with reduced vs preserved ejection fraction were more likely to have 2-week follow-up (adjusted odds ratios 1.67 [95% CI 1.62-1.73] and 1.72 [95% CI 1.67-1.78], respectively) and 1-month follow-up (adjusted odds ratios 1.83 [95% CI 1.78-1.88] and 1.85 [95% CI 1.80-1.90], respectively). The 1-month follow-up rates varied from 5% to 69% across VA facilities.

conclusionsThe rate of visits with a cardiologist within 2 weeks or 1 month after HF hospitalization was low overall, was at most modestly associated with estimated mortality risk at discharge, and varied by sex, race/ethnicity, and across VA facilities. Increasing the visit rate after HF hospitalization should be evaluated as a mechanism to improve outcomes after HF hospitalizations, particularly for higher-risk individuals.

Indexed as

AftercareCardiologyHeart FailureHospitalizationVeteransAgedAged, 80 and overCohort StudiesFemaleFollow-Up StudiesHospitals, VeteransHumansMaleMiddle AgedPatient DischargeRetrospective Studiesambulatory careHeart failure

Identifiers

PMID39778675
PMCPMC12228829

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.